Microbio is an Australian biotech startup that plans to change the course of pathogen detection. Our novel diagnostic method combines the latest advances in bioinformatics, genomics and molecular microbiology to deliver rapid pathogen detection using qPCR. Developed in collaboration with Australian clinicians, Microbio’s flagship product InfectID-BSI has been designed with clinical decision-making in mind, to… Continue reading Introducing Microbio
News
Microbio Shareholder Rights to Receive Documents
Microbio Shareholder Notice of Rights to Receive Documents
Microbio appoints Colin Keating as CEO
Brisbane, 24 October 2023 – Microbio Ltd, an Australian molecular pathogen diagnostics company, is pleased to announce the appointment of Colin Keating as CEO, effective from 1 November 2023. Mr Keating joined Microbio as interim COO in May and assumed the role of interim CEO in early June. Mr Keating’s experience delivering transformation programs at… Continue reading Microbio appoints Colin Keating as CEO
Microbio featured on Smart Company
Microbio has been featured by Smart Company in an article highlighting the commercialisation of InfectID-BSI and how it has benefitted from our participation in the Brisbane Economic Development Agency’s MedTech Accelerator program. Microbio develops pathogen test to identify and treat sepsis (smartcompany.com.au)
September is Sepsis Awareness Month
Every September the world marks Sepsis Awareness Month. This year Microbio celebrates the incredible work undertaken by sepsis organisations around the world, who are raising awareness, advocating for survivors and improving sepsis management. Follow us on LinkedIn and X to find out the latest statistics, learn the signs and read the stories of sepsis patients… Continue reading September is Sepsis Awareness Month